Nettoinventarwert (NAV)
| 648.32 USD | 8.78 USD | 1.37 % |
|---|
| Vortag | 639.54 USD | Datum | 19.10.2026 |
HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap USD Fonds Kurs - 1 Jahr
Fundamentaldaten
| Valor | 35004489 |
| ISIN | LU1540962054 |
| Name | HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap USD Fonds |
| Fondsgesellschaft | HBM Partners |
| Aufgelegt in | Luxembourg |
| Auflagedatum | 06.09.2017 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 14’778’446.22 |
| Depotbank | Pictet & Cie (Europe) S.A. (Luxembourg) |
| Zahlstelle | FundPartner Solutions (Europe) S.A. |
| Fondsmanager | Ivo Staijen |
| Geschäftsjahresende | 31.12. |
| Berichtsstand | 20.10.2026 |
Anlagepolitik
So investiert der HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap USD Fonds: The investment objective of the Sub-Fund is to achieve long-term capital growth. The goal is to generate a value trend that exceeds the performance of the NASDAQ Biotechnology Index (the “Benchmark”). No guarantee can be given that the investment objective will be achieved.